Key Takeaways
The drugVeozah (fezolinetant).
Hormone replacement therapyhas long been the gold standard for treating symptoms of menopause.
Those taking a placebo averaged more than five hot flashes in the same period.
Illustration by Mira Norian for Verywell Health.
Scientists are still learning about the reasons for the associations between vasomotor symptoms and certain chronic conditions.
The studies also included people with abody mass index(BMI) over 25.
BMI is a dated, flawed measure.
It does not take into account factors such asbody composition, ethnicity, sex, race, and age.
The data presented this week affirmed the safety of Veozah treatment.
Most of the reported side effects were mild, like headaches and respiratory illnesses.
Compared to thedecades of datato understand the effects of hormone therapy, studies on Veozah are still relatively nascent.
Obstetrics & Gynecology2023;141(4):737-747. doi:10.1097/AOG.0000000000005114
American Cancer Society.Menopausal hormone therapy after breast cancer.
North American Menopause Society abstract P-63.
2017;17(1):126. doi:10.1186/s12905-017-0487-7
